ArticleFrontiers in surgery2026
A comparative study on percutaneous vertebroplasty for osteoporotic vertebral compression fractures under day surgery and inpatient management models.
Article in Frontiers in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To compare the clinical efficacy, safety and health economic differences of percutaneous vertebroplasty for osteoporotic vertebral compression fractures (OVCF) under the day surgery and conventional inpatient management modes. Methods: A retrospective cohort study was conducted. A total of 168 OVCF patients who underwent percutaneous vertebroplasty from March 2023 to December 2024 were included, with 86 cases in the day surgery group, who completed admission, surgery, postoperative observation and discharge within one working day, and 82 cases in the inpatient group, who stayed overnight after surgery or had a total hospital stay of more than 24 h. The grouping was based on: patients who met the hospital's day surgery admission criteria and had perfect home care conditions after receiving standardized outpatient evaluation, anesthesia evaluation and perioperative risk stratification were included in the day surgery pathway; those who adopted the conventional inpatient process due to comorbidities requiring extended observation, long preoperative evaluation time, insufficient home care or patient's wishes were included in the inpatient group. The visual analogue scale (VAS) score, Oswestry disability index (ODI), analgesic medication use score and mobility score were compared between the two groups before surgery, 1 week after surgery and at the last follow-up. Meanwhile, the direct medical costs, patient satisfaction, surgery-related indicators and perioperative complications were compared between the two groups. Results: There were no statistically significant differences in baseline data between the two groups (all Conclusion: For strictly screened OVCF patients, percutaneous vertebroplasty under the day surgery mode can achieve short-term and early medium-term efficacy equivalent to that of inpatient management, without increasing the risk of perioperative complications, and can significantly shorten the hospital stay, reduce direct medical costs and improve patient satisfaction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.